Answers are grounded in this paper and cite their sources.
The pathological differentiation of type 2 intraductal papillary neoplasm of the bile duct (IPNB) from type 1 is important. Utilizing 19 type 1 and 20 type 2 IPNB surgical specimens, the presence of pericryptal myofibroblast-like cells (PCMLCs) and amounts of IgA- and IgG-positive plasma cells (IgA-P, IgG-P), and CD117-positive mast cells (mast cells) and their diagnostic utility for IPNB typing were analyzed. PCMLCs were defined as SMA-positive and CD31/ CD34/von Willebrand factor-negative spindle cells. Next, five type 1 and six type 2 biopsy samples were evaluated for diagnostic applicability. As results, PCMLCs were absent in all type 1 cases except for the oncocyic subtype and present in all type 2 cases. IgA-P, IgG-P, and mast cells were significantly more abundant in type 2 than type 1. Receiver-operating characteristic analysis identified diagnostic cutoff values. All type 2 biopsy specimens, but none of the type 1, harbored PCMLCs. The established cutoff values were valid in most (> 80%) cases across both groups. In conclusion, type 2 IPNB is characterized by iLP-type stroma featuring PCMLC formation and abundant IgA-P, IgG-P, and mast cell-infiltration, whereas type 1 IPNB is not. Combined IgA quantification and PCMLC detection may provide a robust diagnostic approach for IPNB typing.
No takes yet. Share an insight, caveat, or question.
Maimaitituerxun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: